CellCarta

In News

Tempus AI (TEM) Joins CellCarta Network, Is The Stock Still Undervalued? - simplywall.st

simplywall.st - Aug 20, 2026

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development - PR Newswire

PR Newswire - Jul 15, 2026

CellCarta adds Tempus to CDx Commercialization Lab Network - Select Science

Select Science - Aug 12, 2026

Tempus Hub Will Support Oncology Test Orders in CellCarta Deal - Stock Titan

Stock Titan - Aug 06, 2026

Revolune Announces Service Provider Program with CellCarta, Concept Life Sciences, and Propath UK - Yahoo Finance

Yahoo Finance - Aug 04, 2026

CellCarta Eliminates 9-Hours-Per-Week Regulatory Bottleneck with RegASK’s AI-Driven Intelligence Platform - Business Wire

Business Wire - Apr 21, 2026

CellCarta and Pillar Biosciences Partner to Expand Tumor Profiling for Oncology Trials - Clinical Lab Products

Clinical Lab Products - Apr 02, 2026

CellCarta Adds Tempus to CDx Commercialization Lab Network - PR Newswire

PR Newswire - Aug 06, 2026

CellCarta, Pillar Biosciences Partner to Expand Access to Tumor Profiling - Contract Pharma

Contract Pharma - Apr 02, 2026

Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test - simplywall.st

simplywall.st - Aug 09, 2026

CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network - Yahoo Finance

Yahoo Finance - May 27, 2026

CellCarta Secures Exclusive Global Rights to Deploy Aspyre Lung Assay in Lung Cancer Clinical Trials - Clinical Lab Products

Clinical Lab Products - Apr 17, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment